Improvement in health-related quality of life in systemic lupus erythematosus patients enrolled in a randomized clinical trial comparing LJP 394 treatment with placebo

Abstract
In a 76-week, randomized controlled trial, patients received 100mg LJP 394 or placebo weekly for 16 weeks followed by three 12-week treatment cycles of 50mg LJP 394 or placeboweekly each separated ...

This publication has 0 references indexed in Scilit: